WSNAFWESANA HEALTH HLDGS INC.

About WESANA HEALTH HLDGS INC. (WSNAF)

WESANA HEALTH HLDGS INC. (WSNAF) is a Biotechnology company headquartered in Chicago, IL, United States whose shares trade over-the-counter on the Pink tier.

Wesana Health ("Wesana") is an integrated life science company pioneering drug development, clinical therapy, and remote patient monitoring solutions for psychedelic medicine in mental health. Wesana helps people transcend barriers in mental health and performance. We innovate in care development through our therapies and proprietary protocols, and in care delivery through activating a new multidisciplinary, technology-supported clinical model. Learn more at www.wesanahealth.com.

Products and services

Wesana Health is an emerging life sciences company championing the development and delivery of therapies, including psychedelics, to treat traumatic brain injury (TBI) and related conditions. Through extensive clinical research and academic partnerships, we’re developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.

WSNAF key facts

Ticker symbol

WSNAF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Chicago, IL, United States

Country of incorporation

CA

Employees

5

Estimated market cap

$742.8K (as of Apr 11, 2025)

Shares outstanding

20,633,772

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Interim Financial Report (Sep 30, 2023)

WESANA HEALTH HLDGS INC. leadership

• Daniel Carcillo — CEO
• Winfield Ding — CFO
• Mark Wingertzahn — Chief Scientific Officer
• Hugh Ferreira — Other

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with W